Discontinued — last reported Q3 '23
McKesson Prescription Technology Solutions — Total operating profit increased by 3.0% to $238.00M in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 98.3%, from $120.00M to $238.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved operational efficiency, higher service margins, or successful scaling of technology solutions within the pharmaceutical ecosystem. A decrease may signal rising operational costs, competitive pricing pressures, or a slowdown in the adoption of the segment's digital health offerings.
This metric represents the total operating profit generated by the Prescription Technology Solutions business segment, w...
Comparable to operating income or segment profit metrics reported by healthcare technology and pharmacy services divisions at peer pharmaceutical distributors or health-tech firms.
mck_segment_prescription_technology_solutions_total_operating_profit| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $104.00M | $128.00M | $129.00M | $144.00M | $120.00M | $136.00M | $231.00M | $238.00M |
| QoQ Change | — | +23.1% | +0.8% | +11.6% | -16.7% | +13.3% | +69.9% | +3.0% |
| YoY Change | — | — | — | +38.5% | -6.3% | +5.4% | +60.4% | +98.3% |